Fact CheckerSign in

NCT04678115Completed

Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

A Randomized Cross-Over Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

Source: ClinicalTrials.gov · Last updated 22 Apr 2025

Brief summary (registry, in English)

This clinical trial will evaluate two non-surgical devices designed to improve eye lid opening for patients with severe Blepharoptosis (incomplete opening of the eyelids).

Status (registry)
Completed
Study type
Interventional
Enrollment
16 (actual)
First submitted
14 Dec 2020
Start date
Jun 2021
Primary completion date
Dec 2024
Lead sponsor
Massachusetts Eye and Ear Infirmary
NCT number
NCT04678115

What you commit to

  • Study type: Interventional
  • Participants enrolled: 16
  • From Jun 2021 to the primary completion date, Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous ptosis surgery less than 3 months prior to Visit 1.
  • Periocular neurotoxin (eg, Botox, Xeomin, Dysport, Myobloc) injections on the side of the ptosis within 3 months prior to Visit 1 and during the study.

Other illness

  • Presence of a corneal ulcer of any size
  • Severe Cognitive impairment defined as MMSE score less than 18, behaviors consistent with delirium (combinations of disorientation, hallucinations, delusions, and incoherent speech), or lethargy.
  • History of herpes keratitis.
  • History of hyperthyroidism or thyroid eye disease (ie, exophthalmos, upper eyelid retraction, diplopia secondary to extraocular muscle involvement). Hypothyroidism that is controlled on medication is allowed

Age

  • Age less than 5 years

Other

  • Absence of ptosis which occludes the visual axis
  • Presence of corneal hypoaesthesia;
  • Orbicularis weakness on the side of the ptosis
  • Mechanical ptosis, including ptosis due to orbital or lid tumor, cicatricial processes affecting the movements of the upper lid, and enophthalmos.
  • Lid position affected by lid or conjunctival scarring.

Who the study is looking for

  • Presence of ptosis for at least one eye which occludes the visual axis in the resting position (without frontalis drive, lifting with forehead muscles)
  • Moderate cognitive function or better defined as greater than or equal to 18 out of 30 on a pre-screening of the Mini-Mental State Exam (MMSE)

Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts Eye and Ear
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.